Luigi Qiu

6PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Tumour immunologyMedical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 20, 2026
Continuous or fixed-duration BTK inhibitor treatment for WM.

|Mar 05, 2026
Proteogenomic features define subtypes of mantle cell lymphoma.

Yuting Yan, Weihao Chen, Xinzhou Ge

|Feb 11, 2026
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia.

Hao Sun, Romanos Sklavenitis Pistofidis, Shirong Liu

|Jan 09, 2025
Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma.

Qin Yang, Yinghong Zhu, Xingxing Jian

|Sep 24, 2024
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE.

Jennifer R Brown, Barbara Eichhorst, Nicole Lamanna

|Jun 11, 2024
Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies.

Shuhui Deng, Sanika Derebail, Vera Joy Weiler

Pageof 1

Frequent Collaborators

3 joint publications

Shuhua Yi

2 joint publications

Mu Hao

2 joint publications

Gang An

1 joint publications

Jingyi Jessica Li